Benzodiazepines Linked to Minimal Birth Defect Risk
A large study suggests first-trimester benzodiazepine use does not significantly increase the risk of major birth defects.
Updated on Oct. 12, 2026 in Pregnancy
Live Poll
Would you trust new medical findings to change your medication habits during pregnancy?
Researchers found no substantial link between first-trimester benzodiazepine exposure and major congenital malformations in live births. The findings draw on data from millions of publicly and commercially insured pregnancies across the United States.
Why it matters
Understanding the safety of medications during pregnancy is critical for families navigating anxiety or other health conditions. This large-scale analysis offers clarity for expectant parents and their doctors when evaluating treatment options.
The study analyzed 2.5 million publicly insured and 1.75 million commercially insured pregnancies, finding that 2.1% and 1.6% of these groups respectively filled benzodiazepine prescriptions during the first trimester.
The players
Brigham and Women's Hospital
A Boston-based teaching hospital affiliated with Harvard Medical School that conducts extensive clinical and public health research.
Stanford University
A prominent research institution in California that collaborates on major epidemiological and medical studies.
The details
The study tracked outcomes using medical diagnoses and procedure codes recorded within 90 days after delivery. Researchers applied propensity score fine stratification weights to ensure accuracy across the diverse dataset. While overall risks for malformations remained low, the data indicated that combining benzodiazepines with antiepileptic drugs or mood stabilizers may carry higher risks for gastrointestinal or central nervous system malformations.
Timeline
Medicaid database data was collected from 2000 to 2018.
Merative MarketScan data was collected from 2003 to 2020.
The findings were published in the Annals of Internal Medicine on October 12, 2026.
The Home Front
This research contributes to the growing body of literature aimed at quantifying the safety of common prescriptions for expectant families. It follows the standard rigor of studies published in the Annals of Internal Medicine to refine medical guidance for prenatal health.
Expectant parents should consult their healthcare provider to review any current prescriptions and discuss the findings related to medication combinations. Keep an updated list of all medications, including antiepileptic drugs or mood stabilizers, to share during prenatal checkups.
The takeaway
While this study provides reassuring data on isolated benzodiazepine use, the findings highlight that risks may differ when medications are combined. Always discuss your specific medical history and any concurrent drug therapies with a licensed physician.
Further reading
For more on managing health during pregnancy, see our guide to Pregnancy.
Live Poll
Would you trust new medical findings to change your medication habits during pregnancy?
